CARDIAC DEVELOPMENT DURING SITUS INVERSUS EMBRYOGENESIS
逆位胚胎发生期间的心脏发育
基本信息
- 批准号:6593872
- 负责人:
- 金额:$ 17.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-05-01 至 2003-04-30
- 项目状态:已结题
- 来源:
- 关键词:artificial chromosomes cellular polarity congenital heart disorder developmental genetics embryogenesis gene expression gene targeting genetic mapping genetically modified animals heart laboratory mouse mammalian embryology myogenesis polymerase chain reaction restriction fragment length polymorphism southern blotting
项目摘要
Critical events in early development include the initiation of looping in
the embryonic heart tube, and the concomitant establishment of left-right
asymmetry. Although the molecular events that determine the directions of
looping remain unidentified, a number of genes have recently been
identified that exhibit left-right asymmetric expression prior to the
onset of heart looping. However, these asymmetrically expressed genes do
not appear to be responsible for the initial specification of left-right
asymmetry. Developmental studies of transgenic mice that carry the inv
(inversion of embryonic rotation) insertional mutation suggest that the
inv gene is essential for the earliest stages of left-right axis
specification. Homozygous inv embryos exhibit a consistent reversal of
morphological and molecular left-right asymmetry. In order to begin to
characterize the inv locus, the transgenic integration site was cloned and
characterized. Mapping studies revealed that integration of the transgene
was accompanied by a significant genomic deletion and an intrachromosomal
duplication on mouse chromosome 4. Single-copy genomic sequences flanking
the integration site was used to identify a YAC clone (GO571) that spanned
the deleted region. This YAC was purified and used for microinjection to
generate transgenic mice. Six founder mice that had integrated both arms
of the YAC were identified. Breeding studies revealed that the G0571 YAC
can cure the inv mutant phenotype. Therefore this YAC contains the coding
and regulatory elements of the inv gene. In order to further characterize
this gene and its role in establishing left-right polarity, the following
specific aims are proposed: 1. To identify the coding sequences for the
inv gene (by exon trapping and cDNA library screening). 2. To determine
the embryonic patterns of expression of the candidate inv mRNA and
protein. 3. To characterize changes in expression of asymmetrically
expressed genes (Nodal, lefty, Snail, flectin and dHAND) in YAC-cured
embryos, in chimeric embryos, and in double mutant (iv/iv;inv/inv)
embryos. 4. To construct an inv minigene and to use the minigenes to
identify and characterize the functional domains in the protein. These
experiments should provide molecular details about the earliest steps in
left-right axis specification and the control of cardiac morphogenesis.
早期发展的关键事件包括启动循环
胚胎心管,以及伴随的左右建立
不对称。尽管决定了决定方向的分子事件
循环保持身份不明,最近有许多基因
鉴定出在左右不对称表达之前
心脏循环的发作。但是,这些不对称表达的基因DO
似乎不负责左右的初始规范
不对称。携带INV的转基因小鼠的发展研究
(胚胎旋转的反转)插入突变表明
INV基因对于左右轴的最早阶段至关重要
规格。纯合INV胚胎表现出一致的逆转
形态学和分子左右不对称。为了开始
特征是Inv轨迹,将转基因整合位点克隆,并
特征。映射研究表明,转基因的整合
伴随着明显的基因组缺失和一个内骨体内体
小鼠染色体4的复制。单拷贝基因组序列两侧
集成站点用于识别跨越跨度的YAC克隆(GO571)
删除的区域。该YAC被纯化,用于对
产生转基因小鼠。六只已经整合了双臂的创始人老鼠
确定了YAC的。育种研究表明,G0571 YAC
可以治愈INV突变表型。因此,此YAC包含编码
和INV基因的调节元素。为了进一步表征
该基因及其在建立左右极性中的作用,以下
提出了具体目的:1。确定编码序列
INV基因(通过外显子捕获和cDNA库筛选)。 2。确定
候选INV mRNA和
蛋白质。 3。表征不对称表达的变化
YAC固化的表达基因(淋巴结,左撇子,蜗牛,触发蛋白和DHAND)
胚胎,在嵌合胚和双突变体(IV/IV; Inv/Inv)中
胚胎。 4。要构建一个Inv Minigene并使用微型元素
识别并表征蛋白质中的功能域。这些
实验应提供有关最早步骤的分子细节
左右轴规范和心脏形态发生的控制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul A. Overbeek其他文献
Crystallin genes: lens specificity of the murine alpha A-crystallin gene.
晶状体蛋白基因:鼠αA-晶状体蛋白基因的晶状体特异性。
- DOI:
- 发表时间:
1987 - 期刊:
- 影响因子:10.4
- 作者:
A. B. Chepelinsky;J. Khillan;Kathleen A. Mahon;Paul A. Overbeek;Heiner Westphal;J. Piatigorsky - 通讯作者:
J. Piatigorsky
Promoter sequences of murine alpha A crystallin, murine alpha 2(I) collagen or of avian sarcoma virus genes linked to the bacterial chloramphenicol acetyl transferase gene direct tissue-specific patterns of chloramphenicol acetyl transferase expression in transgenic mice.
与细菌氯霉素乙酰转移酶基因相关的鼠αA晶状体蛋白、鼠α2(I)胶原蛋白或禽肉瘤病毒基因的启动子序列直接指导转基因小鼠中氯霉素乙酰转移酶表达的组织特异性模式。
- DOI:
- 发表时间:
1985 - 期刊:
- 影响因子:0
- 作者:
Heiner Westphal;Paul A. Overbeek;J. Khillan;A. B. Chepelinsky;A. Schmidt;Kathleen A. Mahon;Kenneth E. Bernstein;J. Piatigorsky;B. Crombrugghe - 通讯作者:
B. Crombrugghe
Transposon-mediated insertional mutagenesis in the rat
- DOI:
10.1016/j.ydbio.2010.05.381 - 发表时间:
2010-08-01 - 期刊:
- 影响因子:
- 作者:
Kenryo Furushima;Chuan-Wei Jang;Ningna Xiao;Paul A. Overbeek;Richard R. Behringer - 通讯作者:
Richard R. Behringer
Developmental and tissue-specific expression directed by the a2 type I collagen promoter in transgenic mice
转基因小鼠中a2 I型胶原蛋白启动子指导的发育和组织特异性表达
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
J. Khillan;Azriel SCHMIDTt;Paul A. Overbeek;Benoit;De;CROMBRUGGHEt;Heiner Westphal - 通讯作者:
Heiner Westphal
Paul A. Overbeek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul A. Overbeek', 18)}}的其他基金
Generation and validation of inducible Cre driver lines by enhancer trapping
通过增强子捕获生成和验证诱导型 Cre 驱动线
- 批准号:
7933921 - 财政年份:2006
- 资助金额:
$ 17.52万 - 项目类别:
Generation and validation of inducible Cre driver lines by enhancer trapping
通过增强子捕获生成和验证诱导型 Cre 驱动线
- 批准号:
7676892 - 财政年份:2006
- 资助金额:
$ 17.52万 - 项目类别:
CARDIAC DEVELOPMENT DURING SITUS INVERSUS EMBRYOGENESIS
逆位胚胎发生期间的心脏发育
- 批准号:
6594620 - 财政年份:2002
- 资助金额:
$ 17.52万 - 项目类别:
相似国自然基金
细胞膜磷脂动态分布通过Cdc42信号通路调控真菌细胞极性生长的分子机制
- 批准号:32300020
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CLIP-170家族蛋白Tip1的磷酸化参与细胞极性生长调控的分子机制研究
- 批准号:32370814
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
扩张器包膜通过LAIR-1招募及调节巨噬细胞极性转化的机制研究
- 批准号:82302836
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RACK1通过调控Frizzled/G蛋白/PI3K通路参与小鼠基底膜平面细胞极性发育的机制研究
- 批准号:82301316
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
G蛋白调控平面细胞极性通路影响晶状体纤维排列在老视发病中的作用机制研究
- 批准号:82371040
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
CARDIAC DEVELOPMENT DURING SITUS INVERSUS EMBRYOGENESIS
逆位胚胎发生期间的心脏发育
- 批准号:
6594620 - 财政年份:2002
- 资助金额:
$ 17.52万 - 项目类别:
CARDIAC DEVELOPMENT DURING SITUS INVERSUS EMBRYOGENESIS
逆位胚胎发生期间的心脏发育
- 批准号:
6449409 - 财政年份:2001
- 资助金额:
$ 17.52万 - 项目类别:
CARDIAC DEVELOPMENT DURING SITUS INVERSUS EMBRYOGENESIS
逆位胚胎发生期间的心脏发育
- 批准号:
6311653 - 财政年份:2000
- 资助金额:
$ 17.52万 - 项目类别:
CARDIAC DEVELOPMENT DURING SITUS INVERSUS EMBRYOGENESIS
逆位胚胎发生期间的心脏发育
- 批准号:
6110219 - 财政年份:1999
- 资助金额:
$ 17.52万 - 项目类别:
CARDIAC DEVELOPMENT DURING SITUS INVERSUS EMBRYOGENESIS
逆位胚胎发生期间的心脏发育
- 批准号:
6272932 - 财政年份:1998
- 资助金额:
$ 17.52万 - 项目类别: